How long can you focus on a task without getting distracted? Your attention span can have a major impact on your performance at work or school, and your ability to deal with the tasks of everyday ...

Give that old deck a new lease on life. Expert deck-builders show you how to make your old dilapidated deck look brand new ...

A woman who treated a teenage boy as a 'sex toy' three decades ago has been convicted of sexually assault. Andrea Davey, now 63, had sex twice with the boy and engaged in sexual activity on a ...

Welcome to our Quick Guide to the C-SPAN Video Library. Here you'll find C-SPAN programs by frequently searched categories, a selection of most popular searches, some well-received "fast finds ...

I have dyed my hair every color under the sun, so I know a good shampoo for color-treated hair has a lot to get right. I want one that preserves my new color and undoes some of the damage that ...

African American History, Money & Politics and more. Started 5:06 ET Javascript must be enabled in order to access C-SPAN videos.

These shampoos will keep your colored-treated hair from fading so you always look like you just stepped out of the salon. Our editors and experts handpick every product we feature. We may earn a ...

Chief of Naval Operations Adm. Lisa Franchetti was treated successfully for early-stage breast cancer this summer, the service announced Friday. (Chief Mass Communication Specialist Amanda R.

Unlike their older counterparts, Gen Z suffers from the public perception that they are chronically limited by short attention spans, a habit of laziness and insistence on a robust work-life ...

NEW YORK - The global eradication of smallpox more than 40 years ago was one of the greatest achievements in public health history, vanquishing a cause of death, blindness and disfigurement that ...

On Thursday, the Food and Drug Administration approved for the first time a new type of medicine that may change the way the psychiatric disorder is treated. The drug, called Cobenfy ...

The first patient has been treated in a phase 1/2 clinical trial of an experimental Moderna vaccine designed to generate antibodies against PD-L1 and IDO1 – two targets thought to protect ...